EMV Capital PLC (EMVC) RNS Announcements | Ticker

⌘K

EMV Capital PLC (EMVC) RNS Announcements | Ticker | Ticker

Showing 101–150 of 173 announcements

Showing 101–150 of 173 announcements

EMV Capital PLC RNS

EMV Capital PLC RNS

Date	Time	Date	TitleTitle (filtered)
10/02/23	11:05:35	10 Feb 2023	Second Price Monitoring Extn	Second Price Monitoring Extn
10/02/23	11:00:25	10 Feb 2023	Price Monitoring Extension	Price Monitoring Extension
01/02/23	07:00:09	1 Feb 2023	Board Change	Board Change
03/01/23	13:31:17	3 Jan 2023	PDS Announces Exclusive Global License Agreement	PDS Announces Exclusive Global License Agreement
28/12/22	15:05:26	28 Dec 2022	PDS Biotech: Median Overall Survival announcement	PDS Biotech: Median Overall Survival announcement
16/12/22	07:00:04	16 Dec 2022	PDS: HPV16 Head and Neck Cancer announcement	PDS: HPV16 Head and Neck Cancer announcement
12/12/22	14:00:00	12 Dec 2022	Board Changes; Options; Co-Investment Agreement	Board Changes; Options; Co-Investment Agreement
29/11/22	07:00:08	29 Nov 2022	EMV C leads £4.2m round in 5G and SATCOM leader	EMV C leads £4.2m round in 5G and SATCOM leader
14/11/22	14:50:40	14 Nov 2022	PDS Q3 Results and Business Update	PDS Q3 Results and Business Update
14/11/22	14:05:42	14 Nov 2022	Second Price Monitoring Extn	Second Price Monitoring Extn
14/11/22	14:00:23	14 Nov 2022	Price Monitoring Extension	Price Monitoring Extension
09/11/22	07:00:08	9 Nov 2022	Board Change	Board Change
07/11/22	15:40:57	7 Nov 2022	PDS reports presentation of data at cancer society	PDS reports presentation of data at cancer society
20/10/22	07:00:05	20 Oct 2022	EMV Capital secures investment in Ventive	EMV Capital secures investment in Ventive
11/10/22	16:00:08	11 Oct 2022	PDS Update	PDS Update
03/10/22	13:56:42	3 Oct 2022	PDS completes End-of-Phase 2 meeting with FDA	PDS completes End-of-Phase 2 meeting with FDA
30/09/22	07:00:17	30 Sept 2022	Half-year Report	Half-year Report
25/08/22	07:00:04	25 Aug 2022	PDS Completes $35 Million Financing Agreement	PDS Completes $35 Million Financing Agreement
16/08/22	07:00:11	16 Aug 2022	Acquisition of 30% Vortex stake & new Vortex CEO	Acquisition of 30% Vortex stake & new Vortex CEO
08/08/22	16:45:32	8 Aug 2022	PDS Reports Q2 2022 Results & Business Update	PDS Reports Q2 2022 Results & Business Update
29/06/22	14:05:15	29 Jun 2022	Result of AGM	Result of AGM
28/06/22	09:15:30	28 Jun 2022	Holding(s) in Company	Holding(s) in Company
27/06/22	08:30:01	27 Jun 2022	Director/PDMR Shareholding	Director/PDMR Shareholding
27/06/22	08:30:01	27 Jun 2022	Holding(s) in Company	Holding(s) in Company
22/06/22	07:00:07	22 Jun 2022	Result of Placing and Total Voting Rights	Result of Placing and Total Voting Rights
21/06/22	16:41:41	21 Jun 2022	Proposed Placing to raise at least £1.5 million	Proposed Placing to raise at least £1.5 million
17/06/22	12:00:52	17 Jun 2022	NetScientific to increase Q-Bot stake to 23.7%	NetScientific to increase Q-Bot stake to 23.7%
15/06/22	07:00:04	15 Jun 2022	Q-Bot secures £1.6m of investment to fund growth	Q-Bot secures £1.6m of investment to fund growth
07/06/22	11:07:05	7 Jun 2022	Notice of AGM and Annual Report & Accounts	Notice of AGM and Annual Report & Accounts
06/06/22	07:00:09	6 Jun 2022	PDS Granted FDA Fast Track Designation for PDS0101	PDS Granted FDA Fast Track Designation for PDS0101
27/05/22	14:39:11	27 May 2022	PDS Biotech - new data for ongoing clinical trials	PDS Biotech - new data for ongoing clinical trials
19/05/22	07:00:07	19 May 2022	General Counsel Strategic Hire & Grant of Options	General Counsel Strategic Hire & Grant of Options
16/05/22	07:00:07	16 May 2022	ProAxsis Update	ProAxsis Update
12/05/22	07:00:05	12 May 2022	Final Results	Final Results
11/05/22	15:46:51	11 May 2022	PDS Reports Q1 2022 Results & Business Update	PDS Reports Q1 2022 Results & Business Update
09/05/22	07:00:07	9 May 2022	Notice of Results & Investor Presentation	Notice of Results & Investor Presentation
06/05/22	07:00:06	6 May 2022	Acquisition of 30% of Vortex Biotech Holdings	Acquisition of 30% of Vortex Biotech Holdings
25/04/22	14:05:35	25 Apr 2022	Second Price Monitoring Extn	Second Price Monitoring Extn
25/04/22	14:00:40	25 Apr 2022	Price Monitoring Extension	Price Monitoring Extension
25/04/22	11:05:46	25 Apr 2022	Second Price Monitoring Extn	Second Price Monitoring Extn
25/04/22	11:00:49	25 Apr 2022	Price Monitoring Extension	Price Monitoring Extension
31/03/22	13:24:03	31 Mar 2022	PDS Provides Business Update & Full-Year Results	PDS Provides Business Update & Full-Year Results
04/03/22	07:30:07	4 Mar 2022	Publication of Shareholder Newsletter	Publication of Shareholder Newsletter
24/02/22	16:45:51	24 Feb 2022	PDS Announces Preliminary Safety Data on PDS0101	PDS Announces Preliminary Safety Data on PDS0101
15/02/22	14:32:47	15 Feb 2022	PDS Clinical Trial with Mayo Clinic	PDS Clinical Trial with Mayo Clinic
02/02/22	15:00:01	2 Feb 2022	PDS Phase 2 Trial Update	PDS Phase 2 Trial Update
28/01/22	08:45:21	28 Jan 2022	PDS Announces Preclinical Data for PDS0202 Vaccine	PDS Announces Preclinical Data for PDS0202 Vaccine
18/01/22	07:00:06	18 Jan 2022	Holding(s) in Company	Holding(s) in Company
10/01/22	14:20:06	10 Jan 2022	PDS Granted Novel HPV16 Immunotherapy Patent	PDS Granted Novel HPV16 Immunotherapy Patent
10/01/22	07:00:10	10 Jan 2022	ProAxsis CEO End of Year Update	ProAxsis CEO End of Year Update